A leading U.S. Catholic bishop has issued a blistering condemnation of the FDA\u2019s recent decision to approve a generic version of the abortion drug mifepristone, calling it a \u201cshocking inconsistency\u201d that both endangers women\u2019s health and accelerates the death toll of unborn children. Bishop Daniel E. Thomas of Toledo\u2014a key figure in the U.S. Conference of Catholic Bishops\u2019 pro-life efforts\u2014urged the agency to reverse course immediately, particularly as a federal safety review is already underway. <\/p>\n\n\n\n
Bishop Thomas highlighted the hypocrisy of approving broader access to a drug whose safety is under fresh scrutiny. He pointed out that the FDA is simultaneously conducting a real-world safety study of mifepristone, yet has greenlighted a cheaper, more accessible version before that review is even complete. This, he argued, puts countless women and innocent lives at needless risk. \u201cMothers in need and their preborn children deserve better,\u201d he said. <\/p>\n\n\n\n
The bishop also criticized prior deregulation of the drug under the Biden administration, asserting that reducing oversight and loosening restrictions over time \u201cenabled the killing of more children and placed the health of more women in danger.\u201d He emphasized that the timing is especially egregious given that the HHS has already initiated investigations into serious adverse effects associated with chemical abortion, including hemorrhaging, infection, and sepsis.<\/p>\n\n\n\n
Pro-life groups warn that cheap, generically available mifepristone will flood the market and drive up the abortion rate, particularly when earlier barriers are stripped away. Chemical abortions already account for about 63 % of all abortions in America, with mifepristone used in more than half of those cases. <\/p>\n\n\n\n
Bishop Thomas concluded with a plea: that the ongoing safety review reverse this damaging approval, and that policymakers shift their focus toward real support for women\u2014offering genuine alternatives and care rather than expanding access to abortion. The struggle, he affirmed, is not just legal or political but moral: to safeguard vulnerable lives and uphold the health and dignity of mothers and children alike.<\/p>\n","protected":false},"excerpt":{"rendered":"
A leading U.S. Catholic bishop has issued a blistering condemnation of the FDA\u2019s recent decision to approve a generic version of the abortion drug mifepristone, calling it a \u201cshocking inconsistency\u201d that both endangers women\u2019s health and accelerates the death toll of unborn children. Bishop Daniel E. Thomas of Toledo\u2014a key figure in the U.S. Conference […]<\/p>\n","protected":false},"author":593,"featured_media":266358,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"give_campaign_id":0,"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"mc4wp_mailchimp_campaign":[],"jnews-multi-image_gallery":[],"jnews_single_post":{"format":"standard"},"jnews_primary_category":[],"jnews_social_meta":[],"jnews_override_counter":[],"footnotes":""},"categories":[804,805,808],"tags":[475,909,9863],"class_list":["post-266357","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-breaking-news","category-foreground","category-life","tag-abortion","tag-pro-life-2","tag-right-to-life"],"yoast_head":"\n